Category: Prostate Cancer

When two people have a loving partnership and one of them is diagnosed with cancer, it’s as if they are both slammed by a semi-truck. Although one is the patient, as a couple they are interdependent. This means that over their history of togetherness, be it short of long, they have developed sensitivities to the keep reading

“Look before you leap.” This moral is from a fable called The Fox and the Goat. Its author was an ancient Greek storyteller named Aesop. Though his life is obscure, his legendary fame is based on his tales of animals that have charmed kids while also teaching practical lessons. The Fox and the Goat teaches keep reading

Urologist Bert Vorstman MD continues to be “a keen observer of the state of prostate cancer.” 1 During an interview for the American Society of Clinical Oncology (ASCO), he made some observations in which he did not mince words... keep reading

When it comes to diagnosing localized prostate cancer (PCa), there’s the old world and the new world. Localized PCa means the disease is still contained in the prostate gland at the time of treatment. This knowledge is a crucial key to wise treatment decisions, especially radical treatments aimed at removing or destroying the entire gland. keep reading

According to cancer.net, “A cancer diagnosis often brings concerns about how long your life will be.” Even though prostate cancer (PCa) is not as life-threatening as some other tumor cancers, PCa patients who have just been diagnosed may still encounter fear of death. Yet, the odds of dying from something other than their cancer are keep reading

“Overall, African American men are 1.8 times more likely to be diagnosed with—and 2.2 times more likely to die from—prostate cancer than white men.” (From ZERO The End of Prostate Cancer) This point blank statement is the result of statistics that have remained fairly consistent over recent decades. This data has been the basis for keep reading

Once upon a fairly recent time, radical prostatectomy (RP) was the treatment of choice for prostate cancer (PCa), even for high risk disease. There were two main reasons for this: It was believed that PCa was a multifocal disease scattered throughout the gland, even if too small to be picked up by biopsy. Therefore, aggressively keep reading

We have occasionally posted blogs about the grassroots influence that prostate cancer (PCa) patients can have over trends in PCa treatment. For example, patient desire and demand for less invasive treatments that can diminish their quality of life played an enormous part in the evolution of focal therapies, such as our own Focal Laser Ablation. keep reading

Patients who choose robotic-assisted radical prostatectomy (RARP) believe it’s the best way to eradicate prostate cancer (PCa). In their mind, this equates to a cure. In fact, PCa can recur (come back) as long as 15 or more years after any whole-gland treatment. Increasingly, no one talks about “cure” anymore. Instead, “success” is defined as keep reading

Do you ever regret a decision that turns out to have a bad outcome? This is the situation for many prostate cancer (PCa) patients who chose radical prostatectomy (RP). A 2017 study found that 15% of PCa patients regret their treatment choice, with twice as many patients ruing the day they opted for RP or keep reading